The global femtech market size was estimated to be USD 6.97 billion in 2023 and is expected to reach at USD 25.4 billion by 2033 with a CAGR of 12.48% during the forecast period 2023-2033. Increasing health consciousness among female population, surge in disposable income, digital literacy, smartphone penetration, & internet connectivity, rising digital health infrastructure, growing focus on women’s health, increasing availability of smart wearable devices, rising innovative product development for women’s health issues, surge in technological advancements, growing regulatory approvals of the product by regulatory bodies, and rising funding for programs that promote the health and wellbeing of women are some of the key factors boosting the market growth.
Rising funding for programs that promote the health and wellbeing of women is predicted to boost the market growth during the forecast period. For instance, in November 2022, Maven Clinic, a teletherapy startup specializing in women's health, secured USD 90 million in Series E funding in 2022, making it the largest Femtech round of the year. General Catalyst led the funding round, with Intermountain Ventures, Sequoia Capital, and CVS Health Ventures also participating. Maven's total funding now exceeds USD 300 million, according to the company.
By Type, Devices was the highest revenue-grossing segment in the global Femtech Market in 2022 owing growing demand for smart wearable devices, and rising product approvals by regulatory bodies. For instance, in July 2021, Natural Cycles has received approval and clearance from the U.S. FDA to utilize body temperature data obtained from smart wearables, including the Oura smart ring, to assess female fertility and facilitate pregnancy management. Additionally, Software is predicted to grow at fastest CAGR during the forecast period owing to the to increasing penetration of smartphone, growing technological advancements, and rising introduction of advanced software for women’s health by major market players.
By Product, Wearables was the highest revenue-grossing segment in the global Femtech Market in 2022 owing to rising health consciousness among female users, growing prevalence of women’s health issues, surge in changing trend in favour of value-based care and a model driven by consumers, and increasing advancements in wearables. Additionally, Mobile apps is predicted to grow at fastest CAGR during the forecast period owing to the growing preference for preventive healthcare, increasing use of smartphones and better internet connectivity, rising coverage & ongoing network infrastructure upgrade, surge in adoption of smartphones, growing health consciousness, rising awareness regarding health & well-being among women population, and increasing introduction of advanced applications. For instance, in March 2021, Clue has obtained clearance from the U.S. FDA to introduce Clue Birth Control, a digital contraceptive integrated into the Clue application. This innovative tool uses statistical predictions to anticipate ovulation and aids in birth control management.
By End-user, Hospitals was the highest revenue-grossing segment in the global Femtech Market in 2022 owing to surge in prevalence of women’s health disorders, increasing focus on women’s health, growing healthcare expenditure & infrastructure, and surge in number of female patients suffering from menopause visiting to hospitals. Additionally, Homecare is predicted to grow at fastest CAGR during the forecast period owing to the increasing adoption of remote monitoring, rising technological advancements, and growing partnerships within market players for the introduction of innovative women’s health products. For instance, in September 2022, Embr Labs has formed a strategic partnership to release a revolutionary women's health product designed to offer instant relief from hot flashes experienced during menopause. Embr Wave 2, a stylish wearable that can be cooled or warmed with a simple touch, will now be accessible to women in the United Kingdom.
North America region is anticipated for the highest revenue share during the forecast period owing to the surge in digitalization of healthcare, rising smartphone penetration, growing demand for health-related smart solutions, increasing adoption of smart wearable devices & mobile health applications for health tracking, surge in health consciousness & awareness, rising favourable initiatives by government, growing investment in healthcare by leading market players. For instance, in August 2022, A U.S.-based femtech startup secured USD 3.2 million in seed funding in a round led by Thiel Capital. The company's fitness and wellness pitch attempts to help women understand how their menstrual cycle affects their hormones, providing benefits for both their physical and mental health. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the growing demand for effective health technology, increasing digital health infrastructure, rising penetration of smartphone & wearable devices, surge in number of mobile internet users, growing technological advancements, and increasing initiatives by major market players. For instance, in June 2022, In Japan, companies have introduced 'Femtech' or 'Female technology,' focusing on the health of female employees. This initiative was initiated by the Ministry of Economy, Trade, and Industry in Japan.
Rising funding for programs that promote the health and wellbeing of women is predicted to boost the market growth during the forecast period. For instance, in November 2022, Maven Clinic, a teletherapy startup specializing in women's health, secured USD 90 million in Series E funding in 2022, making it the largest Femtech round of the year. General Catalyst led the funding round, with Intermountain Ventures, Sequoia Capital, and CVS Health Ventures also participating. Maven's total funding now exceeds USD 300 million, according to the company.
By Type, Devices was the highest revenue-grossing segment in the global Femtech Market in 2022 owing growing demand for smart wearable devices, and rising product approvals by regulatory bodies. For instance, in July 2021, Natural Cycles has received approval and clearance from the U.S. FDA to utilize body temperature data obtained from smart wearables, including the Oura smart ring, to assess female fertility and facilitate pregnancy management. Additionally, Software is predicted to grow at fastest CAGR during the forecast period owing to the to increasing penetration of smartphone, growing technological advancements, and rising introduction of advanced software for women’s health by major market players.
By Product, Wearables was the highest revenue-grossing segment in the global Femtech Market in 2022 owing to rising health consciousness among female users, growing prevalence of women’s health issues, surge in changing trend in favour of value-based care and a model driven by consumers, and increasing advancements in wearables. Additionally, Mobile apps is predicted to grow at fastest CAGR during the forecast period owing to the growing preference for preventive healthcare, increasing use of smartphones and better internet connectivity, rising coverage & ongoing network infrastructure upgrade, surge in adoption of smartphones, growing health consciousness, rising awareness regarding health & well-being among women population, and increasing introduction of advanced applications. For instance, in March 2021, Clue has obtained clearance from the U.S. FDA to introduce Clue Birth Control, a digital contraceptive integrated into the Clue application. This innovative tool uses statistical predictions to anticipate ovulation and aids in birth control management.
By End-user, Hospitals was the highest revenue-grossing segment in the global Femtech Market in 2022 owing to surge in prevalence of women’s health disorders, increasing focus on women’s health, growing healthcare expenditure & infrastructure, and surge in number of female patients suffering from menopause visiting to hospitals. Additionally, Homecare is predicted to grow at fastest CAGR during the forecast period owing to the increasing adoption of remote monitoring, rising technological advancements, and growing partnerships within market players for the introduction of innovative women’s health products. For instance, in September 2022, Embr Labs has formed a strategic partnership to release a revolutionary women's health product designed to offer instant relief from hot flashes experienced during menopause. Embr Wave 2, a stylish wearable that can be cooled or warmed with a simple touch, will now be accessible to women in the United Kingdom.
North America region is anticipated for the highest revenue share during the forecast period owing to the surge in digitalization of healthcare, rising smartphone penetration, growing demand for health-related smart solutions, increasing adoption of smart wearable devices & mobile health applications for health tracking, surge in health consciousness & awareness, rising favourable initiatives by government, growing investment in healthcare by leading market players. For instance, in August 2022, A U.S.-based femtech startup secured USD 3.2 million in seed funding in a round led by Thiel Capital. The company's fitness and wellness pitch attempts to help women understand how their menstrual cycle affects their hormones, providing benefits for both their physical and mental health. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the growing demand for effective health technology, increasing digital health infrastructure, rising penetration of smartphone & wearable devices, surge in number of mobile internet users, growing technological advancements, and increasing initiatives by major market players. For instance, in June 2022, In Japan, companies have introduced 'Femtech' or 'Female technology,' focusing on the health of female employees. This initiative was initiated by the Ministry of Economy, Trade, and Industry in Japan.
Segmentation: Femtech Market Report 2022 - 2033
Femtech Market Analysis & Forecast by Type 2022 - 2033 (Revenue USD Bn)
- Software
- Services
- Devices
Femtech Market Analysis & Forecast by Product 2022 - 2033 (Revenue USD Bn)
- Wearables
Mobile Apps
- Fertility Management/ Assisted Reproductive Technology Apps
- Pregnancy Tracking & Postpartum Care
- Menstrual Health
- Menopause
- Disease Management
- Fitness & Nutrition
- Others
Femtech Market Analysis & Forecast by End-user 2022 - 2033 (Revenue USD Bn)
- Homecare
- Fertility Clinics
- Hospitals
- Others
Femtech Market Analysis & Forecast by Region 2022 - 2033 (Revenue USD Bn)
North America
- U.S.
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Femtech Market: Type Estimates & Trend Analysis
8. Femtech Market: Product Estimates & Trend Analysis
9. Femtech Market: End-user Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Femtech Market
12. Europe Global Femtech Market
13. Asia Pacific Global Femtech Market
14. Latin America Global Femtech Market
15. MEA Global Femtech Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- Natural Cycles USA Corp
- HeraMED
- Natural Cycles
- Nuvo Cares
- Sera Prognostics
- NUROKOR LIMITED
- Clue
- Elvie
- iSono Health
- Embr Labs
- Canopie
- Athena Feminine Technologies
- Flo Health Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 145 |
| Published | August 2023 |
| Forecast Period | 2022 - 2033 |
| Estimated Market Value ( USD | $ 6.97 Billion |
| Forecasted Market Value ( USD | $ 25.4 Billion |
| Compound Annual Growth Rate | 12.4% |
| Regions Covered | Global |
| No. of Companies Mentioned | 13 |
